Good dog?

A Dachshund demonstrates her unhappiness with an inappropriate puddle. An over-excited dog jumps on her owner upon his return home. The usually spirited Jack Russell displays signs of depression when left alone. An uncertain German Shepherd barks continuously. A corgi decides that wooden shutters make a good chew toy.

While you may not be familiar with canine separation anxiety, you are probably familiar with its symptoms. While you are gone, your dog may do one or several of the following:

  • Chew destructively
  • Bark or whine
  • Inappropriate urination and/or defecation
  • Drool
  • Pace
  • Tremble
  • Vomit
  • … or worse

Separation anxiety is a clinical condition in your dog's brain. Your pet is not a bad dog. Your pet's behavior is the result of separation anxiety.

Reconcile® is a once-daily, chewable, flavored tablet for the treatment of separation anxiety in conjunction with a behavior modification plan.

Reconcile, approved by the FDA, helps manage separation anxiety and improves your pet's receptivity to a simple training plan also called behavior modification. The four-step BOND™ training plan focuses on reinforcing positive behavior.

Reconcile and the BOND training plan form a logical, easy-to-follow program that makes it possible for you to treat and manage separation anxiety and restore a happy, healthy relationship with your pet.

Important Safety Information

  • The most common adverse reactions recorded during clinical trials with Reconcile® were calm or lethargy, reduced appetite, vomiting, shaking, diarrhea, restlessness, excessive vocalization, aggression, and, in infrequent cases, seizures.
  • Reconcile chewable tablets are contraindicated for dogs with epilepsy or a history of seizures; with drugs that lower the seizure threshold; with a monoamine oxidase inhibitor (MAOI) or within a minimum of 14 days of discontinuing therapy with an MAOI; in dogs with a known hypersensitivity to fluoxetine HCl or other SSRIs.
  • A six week washout interval should be observed following discontinuation of therapy with Reconcile chewable tablets prior to the administration of any drug that may adversely interact with fluoxetine or norfluoxetine.
  • For full product label, including complete safety information, click here.

RE00351-071510

For Veterinary Professionals

Visit ElancoPetProgram.com External Link to learn about our FREE online CE-based (RACE-approved) learning programs.

 
An anxious dog surveys his conquered prey - the couch's pillows.